AACC 2022   Exhibition Review July 26-28th, 2022 AACC Annual Scientific Meeting + Clinical Lab Expo have been held in Chicago, USA. The American Association for Clinical Chemistry (AACC) is a global scientific and medical professional organization dedicated to clinical laboratory science and its application to healthcare. Founded in 1949,  now the AACC Clinical Lab Expo is the world's highest quality and largest annual event in the field of clinical testing, traveling to different cities in the United States every July. The event attracts exhibitors and visitors from 110 countries and regions, and has become a major venue for new product launches, collaborations and networking in the clinical laboratory field.     At the exhibition, Getein Biotech presented its three ace products: Chemiluminescence Immunoassay Analyzer MAGICL 6000, Immunofluorescence Quantitative Analyer Getein 1180 and Getein 1100, showing Getein's latest products and technological hard power in all aspects.     In this exhibition, Getein Biotech adhered to the corporate philosophy of "pursue excellence, deliver health", and while introducing our ace products in detail, we actively interacted with customers, demonstrated the instruments on site and answered their questions. MAGICL6000 is even more brilliant, many customers are interested in this fully automatic high-performance analyzer, have stopped to visit.   This year is also the 20th anniversary of Getein, and many of our customers have offered their blessings to us after learning about Getein's development history. The venue also provided beautiful hand signs for customers to take pictures together. On the 28th, the AACC exhibition also came to a successful end. In this exhibition, many national distributors and medical customers had a better understanding of Getein's ten technology platforms and innovative industrial solutions, and further expanded the company's influence. We will continue to be innovative and pragmatic to further contribute to the global public health cause!

  Hepatitis is an inflammation of the liver that is caused by a variety of infectious viruses and noninfectious agents leading to a range of health problems, some of which can be fatal. An estimated 354 million people worldwide live with hepatitis B or C, and most of them are hard to reach testing and treatment. There are five main strains of the hepatitis virus, referred to as types A, B, C, D and E. While they all cause liver disease, they differ in important ways including transmission modes, severity of the illness, geographical distribution and prevention methods.    Hepatitis B and C Infection  Hepatitis B virus (HBV) and hepatitis C virus (HCV) infection are major causes of acute and chronic liver disease (e.g. liver cirrhosis and liver cancer) globally, and cause an estimated 1.4 million deaths annually.     Testing and diagnosis of hepatitis B and C infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of HBV or HCV infection enables patients to receive the necessary care and treatment to prevent or delay progression of liver disease. Testing also provides an opportunity to link people to interventions to reduce transmission, through counselling on risk behaviors and provision of prevention commodities (such as sterile needles and syringes) and hepatitis B vaccination.     Importance of Testing and Diagnosis of Hepatitis B and C  Most people infected with HBV and/or HCV remain unaware of their infection and therefore frequently present with advanced disease and may transmit infection to others despite the advances and opportunities for treatment.  Getein Reliable Tool for Diagnosis of Hepatitis and Chronic Liver Disease  As a trusted in vitro diagnostic national enterprise in China, Getein has been at the forefront of developing comprehensive tests for HBV & HCV infection and liver disease caused by hepatitis virus infection, which enables healthcare professionals to rapidly and effectively diagnose and control allergies, make informed treatment decisions and improve patient outcomes.     Getein will continuously pay close attention to global health issues and needs in real time, to help combat the pandemic, reduce the burden on healthcare systems and optimize patient management. References: Health topics: Hepatitis. WHO World Hepatitis Day. WHO

Getein at AACC 2022     We sincerely invite you to visit us and to experience our latest innovations!    Date: July, 26-28th, 2022   Location: Chicago, Illinois, McCormick Place Convention Center      Booth No. #1752   Check the following to have a glance at our products that will show in our booth.               Lastly, please check the video here to know more about us at AACC 2022. We are waiting for you!